IBDEI207 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31975,2)
 ;;=^338265
 ;;^UTILITY(U,$J,358.3,31976,0)
 ;;=N85.00^^126^1638^12
 ;;^UTILITY(U,$J,358.3,31976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31976,1,3,0)
 ;;=3^Endometrial Hyperplasia,Unspec
 ;;^UTILITY(U,$J,358.3,31976,1,4,0)
 ;;=4^N85.00
 ;;^UTILITY(U,$J,358.3,31976,2)
 ;;=^331542
 ;;^UTILITY(U,$J,358.3,31977,0)
 ;;=N85.2^^126^1638^13
 ;;^UTILITY(U,$J,358.3,31977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31977,1,3,0)
 ;;=3^Enlarged Uterus
 ;;^UTILITY(U,$J,358.3,31977,1,4,0)
 ;;=4^N85.2
 ;;^UTILITY(U,$J,358.3,31977,2)
 ;;=^270521
 ;;^UTILITY(U,$J,358.3,31978,0)
 ;;=D25.9^^126^1638^14
 ;;^UTILITY(U,$J,358.3,31978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31978,1,3,0)
 ;;=3^Fibroid Uterus
 ;;^UTILITY(U,$J,358.3,31978,1,4,0)
 ;;=4^D25.9
 ;;^UTILITY(U,$J,358.3,31978,2)
 ;;=^5002081
 ;;^UTILITY(U,$J,358.3,31979,0)
 ;;=Z85.42^^126^1638^15
 ;;^UTILITY(U,$J,358.3,31979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31979,1,3,0)
 ;;=3^Hx of Uterine Cancer
 ;;^UTILITY(U,$J,358.3,31979,1,4,0)
 ;;=4^Z85.42
 ;;^UTILITY(U,$J,358.3,31979,2)
 ;;=^5063419
 ;;^UTILITY(U,$J,358.3,31980,0)
 ;;=N81.2^^126^1638^16
 ;;^UTILITY(U,$J,358.3,31980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31980,1,3,0)
 ;;=3^Incomplete Uterovaginal Prolapse
 ;;^UTILITY(U,$J,358.3,31980,1,4,0)
 ;;=4^N81.2
 ;;^UTILITY(U,$J,358.3,31980,2)
 ;;=^5015839
 ;;^UTILITY(U,$J,358.3,31981,0)
 ;;=N85.01^^126^1638^11
 ;;^UTILITY(U,$J,358.3,31981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31981,1,3,0)
 ;;=3^Endomet Hyperpla w/o Atyp
 ;;^UTILITY(U,$J,358.3,31981,1,4,0)
 ;;=4^N85.01
 ;;^UTILITY(U,$J,358.3,31981,2)
 ;;=^338264
 ;;^UTILITY(U,$J,358.3,31982,0)
 ;;=D25.0^^126^1638^17
 ;;^UTILITY(U,$J,358.3,31982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31982,1,3,0)
 ;;=3^Submucous Fibroid
 ;;^UTILITY(U,$J,358.3,31982,1,4,0)
 ;;=4^D25.0
 ;;^UTILITY(U,$J,358.3,31982,2)
 ;;=^267640
 ;;^UTILITY(U,$J,358.3,31983,0)
 ;;=N93.9^^126^1638^18
 ;;^UTILITY(U,$J,358.3,31983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31983,1,3,0)
 ;;=3^Uterine Bleeding
 ;;^UTILITY(U,$J,358.3,31983,1,4,0)
 ;;=4^N93.9
 ;;^UTILITY(U,$J,358.3,31983,2)
 ;;=^5015916
 ;;^UTILITY(U,$J,358.3,31984,0)
 ;;=N85.4^^126^1638^19
 ;;^UTILITY(U,$J,358.3,31984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31984,1,3,0)
 ;;=3^Uterine Malposition
 ;;^UTILITY(U,$J,358.3,31984,1,4,0)
 ;;=4^N85.4
 ;;^UTILITY(U,$J,358.3,31984,2)
 ;;=^270525
 ;;^UTILITY(U,$J,358.3,31985,0)
 ;;=N84.0^^126^1638^20
 ;;^UTILITY(U,$J,358.3,31985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31985,1,3,0)
 ;;=3^Uterine Polyps
 ;;^UTILITY(U,$J,358.3,31985,1,4,0)
 ;;=4^N84.0
 ;;^UTILITY(U,$J,358.3,31985,2)
 ;;=^270517
 ;;^UTILITY(U,$J,358.3,31986,0)
 ;;=N81.4^^126^1638^21
 ;;^UTILITY(U,$J,358.3,31986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31986,1,3,0)
 ;;=3^Uterovaginal Prolapse,Unspec
 ;;^UTILITY(U,$J,358.3,31986,1,4,0)
 ;;=4^N81.4
 ;;^UTILITY(U,$J,358.3,31986,2)
 ;;=^5015841
 ;;^UTILITY(U,$J,358.3,31987,0)
 ;;=O02.0^^126^1639^3
 ;;^UTILITY(U,$J,358.3,31987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31987,1,3,0)
 ;;=3^Blighted Ovum
 ;;^UTILITY(U,$J,358.3,31987,1,4,0)
 ;;=4^O02.0
 ;;^UTILITY(U,$J,358.3,31987,2)
 ;;=^5015978
 ;;^UTILITY(U,$J,358.3,31988,0)
 ;;=O03.9^^126^1639^4
 ;;^UTILITY(U,$J,358.3,31988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31988,1,3,0)
 ;;=3^Complete SAB
